261 related articles for article (PubMed ID: 30603904)
1. Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients.
Song Q; Shang J; Zhang C; Zhang L; Wu X
J Cancer Res Clin Oncol; 2019 Mar; 145(3):737-746. PubMed ID: 30603904
[TBL] [Abstract][Full Text] [Related]
2. Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer.
Zhang C; Mao M; Guo X; Cui P; Zhang L; Xu Y; Li L; Han X; Peltzer K; Xiong S; Baklaushev VP; Wang X; Wang G
BMC Cancer; 2019 Mar; 19(1):238. PubMed ID: 30876473
[TBL] [Abstract][Full Text] [Related]
3. Patterns of bone metastases in newly diagnosed colorectal cancer: a real-world analysis in the SEER database.
Guo X; Zhang C; Ma W; Tian F; Xu G; Han X; Sun P; Baklaushev VP; Bryukhovetskiy AS; Wang G; Ma Y; Wang X
Int J Colorectal Dis; 2019 Mar; 34(3):533-543. PubMed ID: 30617414
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
[TBL] [Abstract][Full Text] [Related]
5. The incidence and clinical impact of bone metastases in non-small cell lung cancer.
Kuchuk M; Kuchuk I; Sabri E; Hutton B; Clemons M; Wheatley-Price P
Lung Cancer; 2015 Aug; 89(2):197-202. PubMed ID: 26003503
[TBL] [Abstract][Full Text] [Related]
6. Risk and prognostic factors of brain metastasis in lung cancer patients: a Surveillance, Epidemiology, and End Results population‑based cohort study.
Hao Y; Li G
Eur J Cancer Prev; 2023 Sep; 32(5):498-511. PubMed ID: 36804864
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of serum bone sialoprotein in patients with bone metastasis of non-small cell lung cancer.
He JJ; Zhi K; Liu GF
Onkologie; 2011; 34(11):584-8. PubMed ID: 22104154
[TBL] [Abstract][Full Text] [Related]
8. Factors for incidence risk and prognosis in non-small-cell lung cancer patients with synchronous brain metastasis: a population-based study.
Zhu H; Zhou L; Guo Y; Yang G; Dong Q; Zhang Z; Chen M; Yang Q
Future Oncol; 2021 Jul; 17(19):2461-2473. PubMed ID: 33706557
[TBL] [Abstract][Full Text] [Related]
9. Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
Goncalves PH; Peterson SL; Vigneau FD; Shore RD; Quarshie WO; Islam K; Schwartz AG; Wozniak AJ; Gadgeel SM
Cancer; 2016 Jun; 122(12):1921-7. PubMed ID: 27062154
[TBL] [Abstract][Full Text] [Related]
10. Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13.
Katakami N; Kunikane H; Takeda K; Takayama K; Sawa T; Saito H; Harada M; Yokota S; Ando K; Saito Y; Yokota I; Ohashi Y; Eguchi K
J Thorac Oncol; 2014 Feb; 9(2):231-8. PubMed ID: 24419421
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in bone metastasis patterns and targeted screening and treatment strategies in newly diagnosed lung cancer patients.
Xu G; Cui P; Zhang C; Lin F; Xu Y; Guo X; Cai J; Baklaushev VP; Peltzer K; Chekhonin VP; Wang X; Wang G
Ethn Health; 2022 Feb; 27(2):329-342. PubMed ID: 32223328
[No Abstract] [Full Text] [Related]
12. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
[TBL] [Abstract][Full Text] [Related]
13. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Homogeneous and Heterogeneous Factors for Bone Metastasis in Esophageal Cancer.
Zhang J; Ma W; Wu H; Wang J; Lin Y; Wang X; Zhang C
Med Sci Monit; 2019 Dec; 25():9416-9425. PubMed ID: 31821313
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
[TBL] [Abstract][Full Text] [Related]
16. Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases.
Huang Z; Hu C; Tong Y; Fan Z; Zhao C
Medicine (Baltimore); 2020 Jul; 99(31):e21339. PubMed ID: 32756121
[TBL] [Abstract][Full Text] [Related]
17. Impact of homogeneous and heterogeneous risk factors on the incidence and prognosis of brain metastases in patients with hepatocellular carcinoma.
Lin X; Zhang P; Huang R; Huang Y; Sun J; Zheng H; Tian X; Wang X
Ann Palliat Med; 2020 Sep; 9(5):2654-2667. PubMed ID: 32921091
[TBL] [Abstract][Full Text] [Related]
18. Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study.
Papotti M; Kalebic T; Volante M; Chiusa L; Bacillo E; Cappia S; Lausi P; Novello S; Borasio P; Scagliotti GV
J Clin Oncol; 2006 Oct; 24(30):4818-24. PubMed ID: 17050866
[TBL] [Abstract][Full Text] [Related]
19. Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases.
Hsiao SH; Chung CL; Chou YT; Lee HL; Lin SE; Liu HE
Lung Cancer; 2013 Nov; 82(2):319-23. PubMed ID: 24018025
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and prognostic factors for inflammatory breast cancer with bone metastasis: A population-based study.
Gao T; Shao F
J Orthop Surg (Hong Kong); 2021; 29(2):23094990211000144. PubMed ID: 34060362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]